The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, April 29, 2020
PharmaMar has announced the start of the APLICOV-PC clinical trial with Aplidin, for the treatment of patients with COVID-19.
read more
Wednesday, April 29, 2020
Review the latest news and information on the COVID-19 Pandemic.
read more
INOVIO announced its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800 is fully enrolled with all 40 healthy volunteers receiving their ...
read more
Pneumagen announced results from three separate in vitro studies into preventing coronavirus infections including SARS-CoV-2 infection the cause of ...
read more
Based on a recommendation by the IDMC to stop the trial early, the trial will be modified to allow all patients to receive Libtayo for this ...
read more
Erba Mannheim announced the development and imminent launch of its ErbaLisa® COVID-19 ELISA kits for detection of IgG and IgM antibodies to SARS-CoV-2...
read more
Citius announced it submitted a pre-IND meeting request to the CBER of the FDA under the Coronavirus Treatment Acceleration Program.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
CNS has filed an application with the FDA to receive Orphan Drug Designation for its lead product Berubicin.
read more
Novartis announced the FDA granted RMAT designation to Kymriah for an investigational new indication to treat patients with relapsed or refractory ...
read more
The HVP is launching the COVID Vaccine Initiative to develop safe, effective, accessible vaccines for those most vulnerable to COVID-19.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
The FDA granted accelerated approval to Trodelvy for triple-negative breast cancer that has spread to other parts of the body.
read more
Theravance Biopharma announced the first healthy volunteer has been dosed in a Phase 1 study of TD-0903.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more